] (unpublished data). To elucidate this apparent discrepancy between the in vitro and the clinical observations, we have studied the interaction between ionized calcium and atracurium or vecuronium in the in vivo animal model. Furthermore, we tested if calcium effects could be modified via central innervation to the muscle.
Waud and Waud measured the effect of ionized calcium on block produced by tubocurarine or pancuronium in vitro, and estimated a 27% variation in dose requirement over a physiological range of concentrations of Ca 2+ (1.06-1.31 mmol litre" 1 ) [1] . In 30 uraemic patients [2] , the serum concentration of ionized calcium ([Ca 2+ ]) was in the range 0.77-1.61 mmol litre" 1 . In these patients we found no association between the responses of neuromuscular blocking agents and [Ca 2+ ] (unpublished data). To elucidate this apparent discrepancy between the in vitro and the clinical observations, we have studied the interaction between ionized calcium and atracurium or vecuronium in the in vivo animal model. Furthermore, we tested if calcium effects could be modified via central innervation to the muscle.
MATERIAL AND METHODS
We used 14 cats, bred for biomedical research at our animal department, of both sexes, age 13.5-21 months and weights between 2.8-5.4 kg.
Anaesthesia and surgical preparation
Anaesthesia was induced with pentobarbitone 20-30 mg kg' 1 i.p. with supplementary i.v. increments as required, and maintained with an i.v. infusion of the barbiturate at a rate of 4-7 mg kg" 1 h -1 using a 0.5 % solution in 3.5 % glucose with 0.3% sodium chloride. Following tracheal intubation, mechanical ventilation was commenced at a rate of 27 b.p.m. with 40 % oxygen in air. The experiment was conducted in stages with control of pH and temperature. Tidal volume was adjusted to maintain pH at 7.30-7.45. Arterial blood-gas tensions and pH were monitored regularly (Radiometer ABL1). A circulating water blanket was used to maintain rectal temperature at 37.5-39.5 °C (Digimed H10 thermometer). A carotid artery was cannulated for blood sampling and arterial pressure monitoring. The ECG was recorded. An external jugular vein was cannulated for infusion of 3.5 % glucose with 0.3 % sodium chloride, containing potassium chloride 4 mmol litre"
1 . When the surgical preparation was completed, this solution also included sodium dihydrogen phosphate 10 mmol litre" 1 . A third vein was cannulated for infusion of the neuromuscular blocking drug. Total fluid load was 7-9 ml kg" 1 h"
1 . The tendon of each anterior tibialis muscle was freed and connected to a Statham UC3 transducer equipped with a UL4-10 load cell. The output of the transducers was registered on a Graphtec Linearcorder WR3101 or a Watanabe Linearcorder WTR331 using Hewlett-Packard 8805C amplifiers. The resting tension of the muscles was held at 45-50 g. Digimed F3 temperature probes were placed subcutaneously on the muscle bellies (unilateral measurements in four cats). A drape of plastic foil (aided occasionally by the radiation of an electric lamp) was used when required to keep muscle surface temperatures at 34.5-37 °C.
The tibial nerves were freed from the peroneal nerves and sectioned near the popliteal space and proximally on the thigh. The peroneal nerve on one side was sectioned likewise proximally, whereas this nerve was saved in the other limb. A shielded bipolar platinum electrode was placed on each peroneal nerve, and supramaximal stimuli were applied at 0.1 Hz (Myotest MKII nerve stimulators). The hind limbs were fixed securely to a rigid frame by pointed clamps at the knees and at the ankles. Wound edges were sutured.
Drugs
Atracurium and vecuronium were diluted in 0.9 % saline to concentrations of 0.3 mg ml" 1 and 0.12 mg ml" 1 , respectively. Calcium chloride 1 mmol ml" 1 was diluted in 5 % glucose to a concentration of 0.05 mmol ml" 1 . A formulation of sodium citrate 230 mg ml" 1 and citric acid 15 mg ml" 1 was diluted with sterile water to a concentration of 0.27 mmol ml" 1 .
Procedure
Seven cats received vecuronium and a consecutive group of seven animals received atracurium. Figure 1 shows the experimental course. The neuromuscular blockers were administrated by continuous infusion, which was titrated to obtain constant infusion-response conditions at consecutive 25%, 50%, 75% and 50% blocks, determined from the muscle without a central innervation. After at least 1 h infusion time at each response level, steady-state conditions were assumed, and the drug requirement and the twitch response were noted. After a subsequent 15-min period of constant-rate infusion the twitch response was re-assessed. While the infusion of the neuromuscular blockers was maintained stable, calcium chloride or citrate was initially infused at a fast constant rate followed by a slow constant-rate infusion to create plateaus of high or low [ ] had not returned to normal 1 h after previous calcium chloride or citrate administration, the infusion of the neuromuscular blocker was prolonged accordingly. [Ca 2+ ] was measured (ICA1 Ionized Calcium Analyzer, Radiometer, Denmark) at each end of a 3-min time interval at the end of the infusion of calcium chloride or citrate, during which period the median change in neuromuscular block was determined.
Initially, during control twitch height we gave calcium chloride to the vecuronium group and citrate to the atracurium group. In all animals calcium chloride was given during the subsequent 25 %, 50 % and 75 % blocks, and citrate was given during the final 50 % block.
Statistics
The Wilcoxon signed mid-rank test was used for analysis of changes within groups. Infusion rate-response relationships were determined by a variance component analysis of individual regressions, using infusion rate as the dependent variable. Differences were considered statistically significant if P < 0.05.
RESULTS
Age and weight in the two groups of cats were (median and total range): atracurium 18.5 months (13.5-21 months) and 4.0 kg (2.8-4.7 kg), vecuronium 18 months (18-18.5 months) and 3.9 kg (3.0-5.4 kg).
The distribution of blocks at the constant infusion-response intervals are shown in figure 2. Even though twitch-to-twitch variation was more pronounced in the muscles with preserved central reflexes, the overall stability of individual responses was similar in both muscles in both drug groups. The median individual changes in twitch height from start to end of these four 15-min intervals (in % of control in absolute values, neglecting the direction of the changes) were: vecuronium group 1.7% and atracurium group 0.8%.
During the last 3 min of the slow infusion sequence of calcium chloride or citrate, the plateaus of increased or decreased [Ca 2+ ] were relatively stable and close to the intended concentrations of about 1.6 and 0.8 mmol litre" 1 , respectively ( fig. 3) ] (absolute values) were 0.02 and 0.01 mmol litre" 1 , respectively, and were similar for both drug groups. There were no major differences in [Ca 2+ ] between the comparative test periods or the two drug groups (table  I) . pH and temperatures were comparable in the various test periods and the two groups (table I) .
In the non-curarized animals, the twitch force was attenuated rapidly when [Ca 2+ ] increased ( ] from start to end of this 3-min time interval were 0.4% (real value: i.e. taking the direction of the change into account) and 0.4 % (absolute value) for both muscles when [Ca 2+ ] was increased. When [Ca 2+ ] was decreased in the non-curarized animal, the corresponding values were 0.4%, 1.0% (centrally denervated muscle) and 0%, 1.3% (centrally innervated muscle).
The increase in [Ca 2+ ] enhanced the twitch ] from normal to about 1.6mmol litre" 1 antagonized the neuromuscular blocking effects of atracurium and vecuronium similarly in the cat. The acute reduction in the concentration of Ca 2+ from normal to about 0.8mmol litre" 1 potentiated both drugs. There were no major differences in the median calcium effects whether the muscle was centrally innervated or not. ] was decreased by about 0.4 mmol litre" 1 during 50 % response, the depression of twitch height was potentiated (single symbols).
Alteration of [Ca 2+ ]
In addition to the effects on [Ca 2+ ], infusions of calcium chloride or citrate may also interact with plasma magnesium. The active ionized fraction of magnesium in human plasma is 55%, and the inactive remainder is either protein-bound (32 %) or chelated as low molecular weight complexes (13%) [3] . For calcium the corresponding approximate values are 45-50 %, 40 % and 10-12 %, respectively [4] .
Pedersen estimated the relationship for the equilibrium between the serum protein binding and the ionic concentrations of these two competitive divalent cations [5] . According to his formulae, the increase of [Ca 2+ ] from 1.2 to 1.6 mmol litre" 1 makes the protein-binding of magnesium about 1 percentage point less, which is negligible. The effect of Ca 2+ on low molecular weight magnesium complexes is unknown.
Infused citrate forms complexes with calcium in addition to magnesium. Because the dissociation constant of calcium citrate and magnesium citrate is the same ( 10~3 22 ) [6] , citrate reduces the concentrations of Mg 2+ and Ca 2+ in the same proportion, provided that there is negligible interaction from other complexing agents. To avoid hypophosphataemia from moderate administration of glucose during the prolonged experimental course, phosphate was added to the infusion fluid [7] . Low concentrations of phosphate in plasma may impair neuromuscular function and hamper the restoration of increased [Ca 2+ ] to normal [8] .
Neuromuscular responses
Effects of varying calcium concentration on atracurium-or vecuronium-induced blocks have not been reported previously. If we assume approximated steady-state conditions during our test periods, the rate of infusion relates directly to drug concentration for the given response. Using an isolated guineapig nerve-lumbrical muscle preparation, Waud and Waud found that the actions of pancuronium and tubocurarine were affected similarly by changes in concentration of calcium [1] . This compares to our finding that calcium interacted similarly with atracurium and vecuronium.
The size of interaction was, however, less in our study than that reported by Waud and Waud. The median change of [Ca 2+ ] from 1.21 to 1.59 mmol litre" 1 increased ED 50 by 7-13% in our in vivo preparations, whereas it can be calculated from the in vitro data of the former workers that a similar increase in [Ca 2+ ] would lead to a 35% increase in ED 50 [1] .
When [Ca 2+ ] was decreased to median 0.78 mmol litre" 1 , the potentiation of atracurium and vecuronium was of similar magnitude as the antagonism observed at high [Ca 2+ ]. As discussed above, the decrease in [Ca 2+ ] produced by citrate is accompanied by a proportional reduction in plasma concentration of ionized magnesium ([Mg 2+ ]). To our knowledge, it has not been reported how the action of neuromuscular blocking drugs is affected by hypomagnesaemia. Because a reduction in [Mg 2+ ] markedly increases the amount of evoked acetylcholine released from the motor nerve terminal [9] , it is likely that these non-depolarizing agents are antagonized by low [Mg 2+ ]. Accordingly, we have probably underestimated the interaction with atracurium and vecuronium caused by low [Ca 2+ ]. However, the pronounced depression of twitch responses associated with the citrate infusion shows that a decrease in [Mg 2+ ] has considerably less effect on the neuromuscular blocking action of atracurium and vecuronium than a proportional decrease in [Ca 2+ ].
Ca 2+ interactions were similar in the centrally innervated and denervated limb. Therefore, the disagreement between our clinical and the reported in vitro findings cannot be explained by centrally mediated neural activity masking the direct action of Ca 2+ at the neuromuscular junction.
Even though acute changes in [Ca 2+ ] produced statistically significant interactions with atracurium and vecuronium, the magnitude of these effects might be considered clinically insignificant. This would agree with the lack of association between [Ca 2+ ] and the potency of neuromuscular blockers in renal failure patients. Such patients have large inter-individual differences in their sensitivity to neuromuscular blocking drugs [2] , which confounds moderate interactions of Ca 2+ . The normal physiological range of [Ca 2+ ] in other patients probably affects the drug responses negligibly.
